Aigen Investment Management LP grew its stake in Chemed Co. (NYSE:CHE - Free Report) by 300.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,002 shares of the company's stock after purchasing an additional 1,502 shares during the period. Aigen Investment Management LP's holdings in Chemed were worth $1,061,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also made changes to their positions in the company. UMB Bank n.a. grew its position in shares of Chemed by 300.0% in the fourth quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Trust Co. of Vermont purchased a new stake in shares of Chemed in the fourth quarter valued at approximately $34,000. SRS Capital Advisors Inc. grew its position in shares of Chemed by 39.2% in the fourth quarter. SRS Capital Advisors Inc. now owns 135 shares of the company's stock valued at $72,000 after purchasing an additional 38 shares in the last quarter. Allworth Financial LP grew its position in shares of Chemed by 2,057.1% in the fourth quarter. Allworth Financial LP now owns 151 shares of the company's stock valued at $83,000 after purchasing an additional 144 shares in the last quarter. Finally, Farther Finance Advisors LLC grew its position in shares of Chemed by 2,314.3% in the third quarter. Farther Finance Advisors LLC now owns 338 shares of the company's stock valued at $203,000 after purchasing an additional 324 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Separately, StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research report on Friday.
Get Our Latest Research Report on CHE
Chemed Stock Performance
Shares of CHE traded up $1.51 during midday trading on Friday, hitting $595.86. 124,996 shares of the stock were exchanged, compared to its average volume of 99,602. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $654.62. The stock has a fifty day simple moving average of $553.87 and a 200 day simple moving average of $564.10. The firm has a market cap of $8.72 billion, a P/E ratio of 30.11, a P/E/G ratio of 2.15 and a beta of 0.43.
Chemed Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be given a dividend of $0.50 per share. The ex-dividend date is Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. Chemed's dividend payout ratio is currently 10.05%.
Insider Transactions at Chemed
In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the sale, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Brian C. Judkins acquired 145 shares of Chemed stock in a transaction dated Monday, December 30th. The stock was bought at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the completion of the purchase, the vice president now owns 1,678 shares of the company's stock, valued at approximately $871,721. This represents a 9.46 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 3.32% of the company's stock.
About Chemed
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Further Reading
Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
